A B2B marketplace that helps LMIC governments, hospitals, and NGOs source prequalified medicines, aggregate demand for 35%+ savings, and track delivery end to end.

Is Axmed right for you?
Best for
- Public hospitals
- Health NGOs
- Government buyers
- Medicine procurement teams
- Cross-border buyers
What it does well
- Prequalified medicine sourcing
- Bulk demand pooling
- Lower procurement costs
- End-to-end delivery tracking
- B2B buying workflow
Things to check
- Medicine list coverage
- Supplier prequalification rules
- Delivery time windows
- Import and customs handling
- Nigeria Kenya South Africa
Axmed is a web-based B2B marketplace for healthcare procurers in low and middle-income countries (LMICs) to source medicines and health products from prequalified pharmaceutical suppliers.
Key capabilities include:
- Demand aggregation and pooled procurement to reduce fragmented purchasing and support 35%+ average cost savings on medicines and health products (reported for 2025)
- Supplier and product access across 5,000+ products in 10+ therapeutic areas, connecting procurers to local, regional, and international suppliers
- End-to-end logistics integrated with top 10 global logistics partners, including real-time tracking from order to delivery
- Procurement analytics and business insights to support data-driven decisions, plus improved payment terms to help with financing planning
Available on Web (via the marketplace platform).
Target users include governments, hospitals, NGOs, and faith-based organizations procuring medicines in LMICs, plus pharmaceutical manufacturers and distributors looking to access consolidated demand and tendering opportunities.
In African LMIC procurement contexts such as Kenya, Ethiopia, Tanzania, Rwanda, and Nigeria, the platform positions itself around transparent pricing with a 10% markup cap, integrated logistics, and financing mechanisms such as the $5M Gates Foundation-powered MNCH Matching Fund and the Revolving Inventory Financing Facility (RIFF), alongside reported impact including 4.2M patients reached and 1,800 tons delivered in 2025.
Frequently Asked Questions About Axmed
Recent Reviews for Axmed
No reviews yet. Be the first to review this product.
